Pulmonary Rehabilitation in Salt Chambers for Patients With COPD
Title: The Impact of Pulmonary Rehabilitation Conducted in Therapeutic Salt Chambers on the Clinical Condition of Patients with Chronic Obstructive Pulmonary Disease Background and Rationale: Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder that significantly reduces patients' quality
| Condition(s) | COPD (Chronic Obstructive Pulmonary Disease) |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Title: The Impact of Pulmonary Rehabilitation Conducted in Therapeutic Salt Chambers on the Clinical Condition of Patients with Chronic Obstructive Pulmonary Disease Background and Rationale: Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder that significantly reduces patients' quality of life and functional capacity. In the search for supportive therapeutic strategies, there is growing interest in unconventional therapeutic environments such as therapeutic salt chambers. The underground climate of the "Wieliczka" Salt Mine in Poland - characterized by humidity 60-75%, temperature 12.9-14.5°C, high air purity and ionization - has shown therapeutic potential. However, the clinical effects of pulmonary rehabilitation conducted in such an environment in COPD p |
| Who can participate | Inclusion Criteria: * COPD diagnosis confirmed by a pulmonology specialist according to the 2025 GOLD guidelines. * FEV1 ≥ 30% of the predicted value. * FEV1/FVC \< 0.7 after bronchodilator administration in spirometry. * Negative bronchodilator reversibility test. * Voluntary written consent to participate in the study. Exclusion Criteria: * COPD exacerbation. * Active cancer or a history of cancer within the past five years. * Musculoskeletal disorders preventing independent movement and participation in exercise tests and training included in the study protocol. * Recent (within six months) surgical procedure or trauma to the chest, abdomen, skull, brain, or eye area. * Severe valvular heart disease. * Implanted cardioverter-defibrillator. * Diagnosed arrhythmias posing a risk of loss o |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University School of Physical Education, Krakow, Poland |
| Locations | Krakow, Małopolska, Poland |
| Start date | 2025-09-01 |
| NCT ID | NCT07122544 |
| Official listing | https://clinicaltrials.gov/study/NCT07122544 |